FIBERGRAFT Aeridyan Posterolateral Fusion Study
NCT: NCT07059065 · RECRUITING
Brief Summary
This is a post-market, prospective, controlled, multicenter clinical study to evaluate radiographic fusion and clinical outcomes of FIBERGRAFT™ Aeridyan Matrix bone graft substitute in subjects who undergo a 1-3 level instrumented lumbar posterolateral fusion surgery. This clinical study will be conducted at up to 10 clinical sites within the United States.
Frequently Asked Questions
What is FIBERGRAFT Aeridyan Posterolateral Fusion Study?
FIBERGRAFT Aeridyan Posterolateral Fusion Study is a clinical trial registered under NCT07059065. Current status: RECRUITING.
What is the status of NCT07059065?
The current status of NCT07059065 (FIBERGRAFT Aeridyan Posterolateral Fusion Study) is: RECRUITING.
When did FIBERGRAFT Aeridyan Posterolateral Fusion Study start?
FIBERGRAFT Aeridyan Posterolateral Fusion Study started on 2025-08-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.